$ADMA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ADMA BIOLOGICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ADMA BIOLOGICS, INC.. Get notifications about new insider transactions in ADMA BIOLOGICS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | DEMSKI MARTHA J | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Fong Bryant | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Option Exercise | A | 2.35 | 458,700 | 1,077,945 | 458,700 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Grant | A | 0.00 | 221,447 | 0 | 397,545 | 176.1 K to 397.5 K (+125.75 %) |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Option Exercise | A | 2.35 | 139,000 | 326,650 | 139,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Grant | A | 0.00 | 64,361 | 0 | 137,535 | 73.2 K to 137.5 K (+87.96 %) |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | EVP, CFO | Option Exercise | A | 2.35 | 139,000 | 326,650 | 139,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | EVP, CFO | Grant | A | 0.00 | 63,936 | 0 | 140,078 | 76.1 K to 140.1 K (+83.97 %) |
| Sep 14 2020 | ADMA | ADMA BIOLOGICS, IN ... | DEMSKI MARTHA J | Director | Buy | P | 2.29 | 2,200 | 5,038 | 4,200 | 2 K to 4.2 K (+110.00 %) |
| Sep 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 2.22 | 5,000 | 11,100 | 160,864 | 155.9 K to 160.9 K (+3.21 %) |
| Sep 10 2020 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Buy | P | 2.20 | 4,000 | 8,800 | 73,174 | 69.2 K to 73.2 K (+5.78 %) |
| Sep 10 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 2.24 | 4,000 | 8,960 | 176,098 | 172.1 K to 176.1 K (+2.32 %) |
| Aug 25 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 2.62 | 300 | 786 | 155,864 | 155.6 K to 155.9 K (+0.19 %) |
| Aug 25 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 2.56 | 5,000 | 12,800 | 155,564 | 150.6 K to 155.6 K (+3.32 %) |
| Aug 14 2020 | ADMA | ADMA BIOLOGICS, IN ... | DEMSKI MARTHA J | Director | Buy | P | 2.88 | 2,000 | 5,760 | 2,000 | 0 to 2 K |
| Aug 13 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 2.90 | 5,000 | 14,475 | 150,564 | 145.6 K to 150.6 K (+3.43 %) |
| Aug 13 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 2.89 | 5,000 | 14,450 | 145,564 | 140.6 K to 145.6 K (+3.56 %) |
| Aug 13 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 2.87 | 200 | 574 | 140,564 | 140.4 K to 140.6 K (+0.14 %) |
| Aug 12 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 2.97 | 1,000 | 2,970 | 172,098 | 171.1 K to 172.1 K (+0.58 %) |
| Aug 12 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 3.04 | 2,000 | 6,080 | 171,098 | 169.1 K to 171.1 K (+1.18 %) |
| Aug 12 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 3.07 | 2,990 | 9,179 | 169,098 | 166.1 K to 169.1 K (+1.80 %) |
| Aug 12 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 3.06 | 10 | 31 | 166,108 | 166.1 K to 166.1 K (+0.01 %) |
| Aug 12 2020 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | EVP, CFO | Buy | P | 2.97 | 4,000 | 11,860 | 76,142 | 72.1 K to 76.1 K (+5.54 %) |
| Aug 12 2020 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Buy | P | 2.88 | 2,000 | 5,750 | 69,174 | 67.2 K to 69.2 K (+2.98 %) |
| Aug 12 2020 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Buy | P | 2.88 | 5,000 | 14,400 | 67,174 | 62.2 K to 67.2 K (+8.04 %) |
| Jun 18 2020 | ADMA | ADMA BIOLOGICS, IN ... | DEMSKI MARTHA J | Director | Option Exercise | A | 2.94 | 30,000 | 88,200 | 30,000 | |
| Mar 23 2020 | ADMA | ADMA BIOLOGICS, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 2.10 | 500,000 | 1,050,000 | 16,584,802 | 16.1 M to 16.6 M (+3.11 %) |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | Fong Bryant | Director | Option Exercise | A | 2.92 | 15,000 | 43,725 | 15,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | Fong Bryant | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 2.92 | 15,000 | 43,725 | 15,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 2.92 | 15,000 | 43,725 | 15,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 2.92 | 15,000 | 43,725 | 15,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Grant | A | 0.00 | 7,500 | 0 | 44,030 | 36.5 K to 44 K (+20.53 %) |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Option Exercise | A | 2.92 | 15,000 | 43,725 | 15,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Grant | A | 0.00 | 7,500 | 0 | 77,500 | 70 K to 77.5 K (+10.71 %) |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Option Exercise | A | 2.92 | 15,000 | 43,725 | 15,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Grant | A | 0.00 | 7,500 | 0 | 140,364 | 132.9 K to 140.4 K (+5.64 %) |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Option Exercise | A | 2.92 | 325,000 | 947,375 | 325,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Grant | A | 0.00 | 100,000 | 0 | 166,098 | 66.1 K to 166.1 K (+151.29 %) |
| Feb 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Buy | P | 3.50 | 20,000 | 70,000 | 70,000 | 50 K to 70 K (+40.00 %) |
| Feb 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | CSO and CMO | Buy | P | 3.50 | 4,285 | 14,998 | 22,174 | 17.9 K to 22.2 K (+23.95 %) |
| Feb 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 3.50 | 22,857 | 80,000 | 22,857 | 0 to 22.9 K |
| Feb 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 3.50 | 22,857 | 80,000 | 132,864 | 110 K to 132.9 K (+20.78 %) |
| Feb 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | EVP, CFO | Buy | P | 3.50 | 7,142 | 24,997 | 32,142 | 25 K to 32.1 K (+28.57 %) |
| Feb 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 3.50 | 57,143 | 200,001 | 878,444 | 821.3 K to 878.4 K (+6.96 %) |
| Feb 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 3.50 | 28,571 | 99,999 | 66,098 | 37.5 K to 66.1 K (+76.13 %) |
| Feb 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 3.50 | 4,563,700 | 15,972,950 | 16,084,802 | 11.5 M to 16.1 M (+39.61 %) |
| Jun 07 2019 | ADMA | ADMA BIOLOGICS, IN ... | Biotest Divestiture Trust | 10% Owner | Sell | S | 3.75 | 5,813,954 | 21,802,328 | 4,295,580 | 10.1 M to 4.3 M (-57.51 %) |
| May 23 2019 | ADMA | ADMA BIOLOGICS, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 4.64 | 250,000 | 1,160,000 | 250,000 | |
| May 23 2019 | ADMA | ADMA BIOLOGICS, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Option Exercise | P | 3.28 | 1,360,000 | 4,457,400 | 1,360,000 | |
| May 23 2019 | ADMA | ADMA BIOLOGICS, IN ... | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | P | 4.00 | 4,000,000 | 16,000,000 | 11,521,102 | 7.5 M to 11.5 M (+53.18 %) |
| May 21 2019 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 4.00 | 12,000 | 48,000 | 110,007 | 98 K to 110 K (+12.24 %) |
| May 21 2019 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Buy | P | 4.00 | 25,000 | 100,000 | 50,000 | 25 K to 50 K (+100.00 %) |
| May 21 2019 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Buy | P | 4.00 | 4,500 | 18,000 | 17,889 | 13.4 K to 17.9 K (+33.61 %) |
| May 21 2019 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | EVP, CFO | Buy | P | 4.00 | 5,000 | 20,000 | 25,000 | 20 K to 25 K (+25.00 %) |
| May 21 2019 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 4.00 | 25,000 | 100,000 | 821,301 | 796.3 K to 821.3 K (+3.14 %) |
| May 21 2019 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 4.00 | 5,000 | 20,000 | 37,527 | 32.5 K to 37.5 K (+15.37 %) |
| Mar 15 2019 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Option Exercise | A | 3.89 | 30,000 | 116,700 | 30,000 | |
| Mar 15 2019 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 3.89 | 30,000 | 116,700 | 30,000 | |
| Mar 15 2019 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Option Exercise | A | 3.89 | 30,000 | 116,700 | 30,000 | |
| Mar 15 2019 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 3.89 | 30,000 | 116,700 | 30,000 | |
| Mar 15 2019 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 3.89 | 30,000 | 116,700 | 30,000 | |
| Mar 15 2019 | ADMA | ADMA BIOLOGICS, IN ... | Fong Bryant | Director | Option Exercise | A | 3.89 | 30,000 | 116,700 | 30,000 | |
| Jan 25 2019 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | EVP, CFO | Option Exercise | A | 3.22 | 200,000 | 644,000 | 200,000 | |
| Jan 25 2019 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Option Exercise | A | 3.22 | 200,000 | 644,000 | 200,000 | |
| Jan 25 2019 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Option Exercise | A | 3.22 | 400,000 | 1,288,000 | 400,000 | |
| Aug 09 2018 | ADMA | ADMA BIOLOGICS, IN ... | Biotest Divestiture Trust | 10% Owner | Sell | S | 0.00 | 8,591,160 | 0 | 0 | 8.6 M to 0 (-100.00 %) |
| Jun 25 2018 | ADMA | ADMA BIOLOGICS, IN ... | Fong Bryant | Director | Option Exercise | A | 4.91 | 17,500 | 85,925 | 17,500 | |
| Jun 25 2018 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 4.91 | 17,500 | 85,925 | 17,500 | |
| Jun 25 2018 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 4.91 | 17,500 | 85,925 | 17,500 | |
| Jun 25 2018 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 4.91 | 17,500 | 85,925 | 17,500 | |
| Jun 25 2018 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Option Exercise | A | 4.91 | 17,500 | 85,925 | 17,500 | |
| Jun 25 2018 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Option Exercise | A | 4.91 | 17,500 | 85,925 | 17,500 | |
| Jun 11 2018 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 4.78 | 31,381 | 150,001 | 31,381 | 0 to 31.4 K |
| Jun 11 2018 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 4.78 | 20,921 | 100,002 | 98,007 | 77.1 K to 98 K (+27.14 %) |
| Jun 11 2018 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 4.78 | 52,301 | 249,999 | 796,301 | 744 K to 796.3 K (+7.03 %) |
| Jun 11 2018 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 4.78 | 20,921 | 100,002 | 32,527 | 11.6 K to 32.5 K (+180.26 %) |
| Jun 11 2018 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Buy | P | 4.78 | 20,000 | 95,600 | 25,000 | 5 K to 25 K (+400.00 %) |
| Jun 11 2018 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | VP, CFO | Buy | P | 4.78 | 5,000 | 23,900 | 20,000 | 15 K to 20 K (+33.33 %) |
| Jun 11 2018 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Buy | P | 4.78 | 5,230 | 24,999 | 36,530 | 31.3 K to 36.5 K (+16.71 %) |
| May 16 2018 | ADMA | ADMA BIOLOGICS, IN ... | Biotest AG | 10% Owner | Sell | S | 0.00 | 8,591,160 | 0 | 0 | 8.6 M to 0 (-100.00 %) |
| Feb 13 2018 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Option Exercise | A | 3.71 | 350,000 | 1,298,500 | 350,000 | |
| Feb 13 2018 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Option Exercise | A | 3.71 | 150,000 | 556,500 | 150,000 | |
| Feb 13 2018 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | VP, CFO | Option Exercise | A | 3.71 | 150,000 | 556,500 | 150,000 | |
| Nov 13 2017 | ADMA | ADMA BIOLOGICS, IN ... | Biotest AG | Director | Buy | P | 2.15 | 5,813,954 | 12,500,001 | 10,109,534 | 4.3 M to 10.1 M (+135.35 %) |
| Nov 13 2017 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Buy | P | 2.15 | 25,000 | 53,750 | 31,300 | 6.3 K to 31.3 K (+396.83 %) |
| Nov 13 2017 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | VP, CFO | Buy | P | 2.15 | 6,500 | 13,975 | 15,000 | 8.5 K to 15 K (+76.47 %) |
| Nov 13 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 2.15 | 485,000 | 1,042,750 | 744,000 | 259 K to 744 K (+187.26 %) |
| Nov 13 2017 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Buy | P | 2.15 | 10,000 | 21,500 | 13,389 | 3.4 K to 13.4 K (+295.07 %) |
| Jul 17 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Option Exercise | M | 2.68 | 42,021 | 112,616 | 0 | |
| Jul 17 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Payment of Exercise | F | 3.30 | 34,126 | 112,616 | 11,606 | 45.7 K to 11.6 K (-74.62 %) |
| Jul 17 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | M | 2.68 | 42,021 | 112,616 | 45,732 | 3.7 K to 45.7 K (+1,132.34 %) |
| Jul 17 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Option Exercise | M | 2.68 | 48,185 | 129,136 | 0 | |
| Jul 17 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Payment of Exercise | F | 3.30 | 39,132 | 129,136 | 77,086 | 116.2 K to 77.1 K (-33.67 %) |
| Jul 17 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | M | 2.68 | 48,185 | 129,136 | 116,218 | 68 K to 116.2 K (+70.83 %) |
| Jul 17 2017 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | M | 2.68 | 2,800 | 7,504 | 0 | |
| Jul 17 2017 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Buy | M | 2.68 | 2,800 | 7,504 | 6,300 | 3.5 K to 6.3 K (+80.00 %) |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | VP, CFO | Option Exercise | A | 3.66 | 192,472 | 704,448 | 192,472 | |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Option Exercise | A | 3.66 | 53,837 | 197,043 | 53,837 | |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Option Exercise | A | 3.66 | 583,224 | 2,134,600 | 583,224 | |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 3.66 | 53,837 | 197,043 | 53,837 | |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Option Exercise | A | 3.66 | 118,861 | 435,031 | 118,861 | |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 3.66 | 78,144 | 286,007 | 78,144 | |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Option Exercise | A | 3.66 | 242,546 | 887,718 | 242,546 | |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 3.66 | 53,837 | 197,043 | 53,837 | |
| Jun 08 2017 | ADMA | ADMA BIOLOGICS, IN ... | Fong Bryant | Director | Option Exercise | A | 3.66 | 53,837 | 197,043 | 53,837 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | Fong Bryant | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | CSO/CMO | Option Exercise | A | 5.00 | 22,500 | 112,500 | 22,500 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Option Exercise | A | 5.00 | 55,000 | 275,000 | 55,000 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | Chief Financial Off ... | Option Exercise | A | 5.00 | 22,500 | 112,500 | 22,500 | |
| Feb 16 2017 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Option Exercise | A | 5.00 | 10,000 | 50,000 | 10,000 | |
| May 05 2016 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | CSO/CMO | Buy | P | 6.50 | 770 | 5,005 | 3,389 | 2.6 K to 3.4 K (+29.40 %) |
| May 05 2016 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | Chief Financial Off ... | Buy | P | 6.50 | 2,500 | 16,250 | 8,500 | 6 K to 8.5 K (+41.67 %) |
| May 05 2016 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 6.50 | 200,000 | 1,300,000 | 843,668 | 643.7 K to 843.7 K (+31.07 %) |
| May 05 2016 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 6.50 | 45,769 | 297,499 | 106,327 | 60.6 K to 106.3 K (+75.58 %) |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | Fong Bryant | Director | Option Exercise | A | 5.96 | 9,000 | 53,640 | 9,000 | |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 5.96 | 9,000 | 53,640 | 9,000 | |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Option Exercise | A | 5.96 | 9,000 | 53,640 | 9,000 | |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Option Exercise | A | 5.96 | 9,000 | 53,640 | 9,000 | |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | RICHMAN ERIC I | Director | Option Exercise | A | 5.96 | 9,000 | 53,640 | 9,000 | |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 5.96 | 9,000 | 53,640 | 9,000 | |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | CSO/CMO | Option Exercise | A | 5.96 | 6,750 | 40,230 | 6,750 | |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | Chief Financial Off ... | Option Exercise | A | 5.96 | 5,750 | 34,270 | 5,750 | |
| Feb 01 2016 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Option Exercise | A | 5.96 | 16,984 | 101,225 | 16,984 | |
| Dec 22 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 8.48 | 4,000 | 33,918 | 60,558 | 56.6 K to 60.6 K (+7.07 %) |
| Dec 22 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 8.47 | 6,400 | 54,224 | 643,668 | 637.3 K to 643.7 K (+1.00 %) |
| Dec 09 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 9.01 | 500 | 4,503 | 56,558 | 56.1 K to 56.6 K (+0.89 %) |
| Dec 09 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 8.99 | 300 | 2,697 | 637,268 | 637 K to 637.3 K (+0.05 %) |
| Dec 09 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 9.01 | 100 | 901 | 636,968 | 636.9 K to 637 K (+0.02 %) |
| Dec 09 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 9.02 | 100 | 902 | 636,868 | 636.8 K to 636.9 K (+0.02 %) |
| Dec 04 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 9.16 | 6,000 | 54,961 | 56,058 | 50.1 K to 56.1 K (+11.99 %) |
| Dec 04 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 9.13 | 750 | 6,848 | 636,768 | 636 K to 636.8 K (+0.12 %) |
| Dec 04 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 9.15 | 1,000 | 9,150 | 636,018 | 635 K to 636 K (+0.16 %) |
| Dec 04 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 9.17 | 500 | 4,586 | 635,018 | 634.5 K to 635 K (+0.08 %) |
| Dec 03 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 9.17 | 1,800 | 16,513 | 634,518 | 632.7 K to 634.5 K (+0.28 %) |
| Dec 03 2015 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | Chief Financial Off ... | Buy | P | 9.14 | 500 | 4,568 | 6,000 | 5.5 K to 6 K (+9.09 %) |
| Dec 03 2015 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | Chief Financial Off ... | Buy | P | 9.15 | 250 | 2,288 | 5,500 | 5.3 K to 5.5 K (+4.76 %) |
| Dec 03 2015 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | Chief Financial Off ... | Buy | P | 9.18 | 250 | 2,295 | 5,250 | 5 K to 5.3 K (+5.00 %) |
| Nov 30 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 9.18 | 1,800 | 16,529 | 632,718 | 630.9 K to 632.7 K (+0.29 %) |
| Nov 23 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 9.26 | 2,500 | 23,146 | 630,918 | 628.4 K to 630.9 K (+0.40 %) |
| Nov 23 2015 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President & CEO | Buy | P | 9.12 | 361 | 3,293 | 628,418 | 628.1 K to 628.4 K (+0.06 %) |